Christopher Pruss

Neuroscience Sales Specialist at Biohaven Pharmaceutical Holding Company, Ltd - New Haven, Connecticut, US

Christopher Pruss's Colleagues at Biohaven Pharmaceutical Holding Company, Ltd
Amy ODonnell

Vice President, Head of Pharmacovigilance

Contact Amy ODonnell

Debbie Connell

Neuroscience Sales Specialist

Contact Debbie Connell

Cara Carson

Neuroscience SalesSpecialist

Contact Cara Carson

Laura Heller

Executive Director, Medical Affairs

Contact Laura Heller

Chuck Yaeger

Neuroscience Sales Specialist

Contact Chuck Yaeger

David Leahy

Senior Director, Chemistry Manufacturing and Controls

Contact David Leahy

Jane Arnison

Neuroscience Sales Specialist

Contact Jane Arnison

View All Christopher Pruss's Colleagues
Christopher Pruss's Contact Details
HQ
(203) 404-0410
Location
Bridgewater, New Jersey, United States
Company
Biohaven Pharmaceutical Holding Company, Ltd
Christopher Pruss's Company Details
Biohaven Pharmaceutical Holding Company, Ltd logo, Biohaven Pharmaceutical Holding Company, Ltd contact details

Biohaven Pharmaceutical Holding Company, Ltd

New Haven, Connecticut, US • 1000 - 4999 Employees
BioTech/Drugs

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. Biohaven obtained licenses from Yale University School of Medicine and Massachusetts General Hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. The mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. The company’s first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. Biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at Yale University who discovered the therapeutic potential of glutamate modulation in anxiety and depression. Team members have designed and executed successful development programs testing a variety of agents in affective disorders, leading to first-cycle FDA approvals and successful commercialization.

Biohaven Rimegepant Biohaven Pharmaceuticals Tanya Berbsava @Kleopharmaceuticals.Com Calcitonin Gene-Related Peptide (Cgrp
Details about Biohaven Pharmaceutical Holding Company, Ltd
Frequently Asked Questions about Christopher Pruss
Christopher Pruss currently works for Biohaven Pharmaceutical Holding Company, Ltd.
Christopher Pruss's role at Biohaven Pharmaceutical Holding Company, Ltd is Neuroscience Sales Specialist.
Christopher Pruss's email address is ***@biohavenpharma.com. To view Christopher Pruss's full email address, please signup to ConnectPlex.
Christopher Pruss works in the BioTech/Drugs industry.
Christopher Pruss's colleagues at Biohaven Pharmaceutical Holding Company, Ltd are Amy ODonnell, Debbie Connell, Cara Carson, Laura Heller, Chuck Yaeger, David Leahy, Jane Arnison and others.
Christopher Pruss's phone number is (203) 404-0410
See more information about Christopher Pruss